Table of Contents
- A detailed and comprehensive overview of current financial position,
company strategy, product and pipeline analysis.
- THERAPEUTIC AREA FOCUS
- Key product analysis and forecasting
- Neurosciences
- Botox/Dysport (botulinum toxin)
- Opthalmology
- Alphagan/Alphagan P (brimonidine tartrate solution)
- Lumigan (bimatoprost solution)
- Restasis (ciclosporin emulsion)
- Urology
- Sanctura (trospium)
- OPERATIONAL DATA
- A wealth of background and detail
- A full 5-year financial performance assessment
- Key agreements
- Infrastructure
- Subsidiaries and joint ventures
|
Related Report
|